Communications 12th

Communications

 
Pierre DROUIN Lecture: “Diabetes and vitamin D”
S. Maggi (Italy)
Abstract
Slide set

SESSION A: Diabetes and co-morbidities

– Lecture: “Diabetes and nephropathy: state of the art”
M. Marre (France)
Slide set

Presentations of the 4 best abstracts selected:

Polymorphismes génétiques du gène de l’adiponectine et des gènes de ses récepteurs dans le diabète de type 2
I. Slim (Tunisia)

Allele scoring of genetic risk in previous gestational diabetes mellitus
S.Y. Abou-Hussein (Malta)
Slide set

Early metabolic imprinting and lifestyle risk factors as determinants of childhood obesity
Ch. Scerri (Malta)
Slide set

Diabetes induces oxidative stress and cell death at a serotoninergic brainstem key area involved in pain control: a role in painful diabetic neuropathy?
C. Morgado (Portugal)

SESSION B: ADVANCEd management of type 2 diabetes: Guidelines and clinical evidence

Introduction
C. Ben Slama (Tunisia)
Slide set

New Guidelines in type 2 diabetes: rationale and choices
S. Colagiuri (Australia)
Abstract

The ADVANCE trial: update and new results
J.-F. Gautier (France)
Abstract
Slide set

Practical implementation of the ADVANCE results in real life
D. Carvalho (Portugal)
Abstract
Slide set

Place of Diamicron MR amongst insulinosecretagogues
A. Avogaro (Italy)
Abstract

Conclusion: S. Colagiuri (Australia)

Short Oral presentations of 8 posters (1st series)

Vitamin D and mortality: the Progetto Veneto Anziani (Pro.V.A.) study
S. Zanoni (Italy) – Presented by S. Zambon (Italy)
Abstract
Slide set

Relationship between osteoarthritis and diabetes
P. Siviero (Italy) – Presented by S. Zambon (Italy)
Abstract
Slide set

Effect of a dipeptidyl peptidase –IV inhibitor in diabetic retina: study in a model of type 2 diabetes
C. Fontes Ribeiro (Portugal) – Presented by R. Fernandes (Portugal)
Abstract
Slide set

A Gly482Ser polymorphism of the Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 (PGC-1) Gene is associated with Type 2 diabetes in Tunisian population
R. Jemaa (Tunisia)
Slide set

A common functional polymorphism (C → A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF- α) gene is associated with type 2 diabetes in the Tunisian population
A. Kallel (Tunisia)

Integrated analysis of mechanisms of early onset of diabetic nephropathy
C. Kifagi (Tunisia)
Abstract

Metabolic syndrome, incidence of diabetes and mortality among elderly: the Italian longitudinal study on aging
M. Noale (Italy) – Presented by S. Maggy (Italy)
Abstract
Slide set

Diabetes as a risk factor for cognitive decline in older patients
F. Limongi (Italy)
Abstract
Slide set

SESSION C: The Gestational Diabetes Study in the Mediterranean region

Rationale
S. Duran-Garcia (Spain)
Abstract
Slide set

Protocol
C. Savona-Ventura (Malta)
Abstract
Slide set

Baseline data and first results
J. Vassallo (Malta)
Abstract

Nutritional aspects
B. Karamanos (Greece)
Abstract
Slide set

General Discussion

SESSION D: Controversies: is lower better for diabetic patients?

Part 1 – Blood glucose: is lower better for diabetic patients?
Moderator: A. Rovira Loscos (Spain)
Pro: T. Damci (Turkey)
Slide set
Con: N. Albache (Syria)
Abstract
Slide set

Part 2 – Lipids: is lower better for diabetic patients?
Moderator: C. Ben Slama (Tunisia)
Pro: S.H. Assaad-Khalil (Egypt)
Abstract
Slide set
Con: C. Saab (Lebanon)
Abstract
Slide set

Part 3 – Blood pressure: is lower better for diabetic patients?
Moderator: P. Cavallo Perin (Italy)
Pro: J.-M. Halimi (France)
Abstract
Con: F. Jarraya (Tunisia)
Abstract
Slide set

SESSION E: What’s new in diabetes: the SFD reports (Geneva, March, 2011)

Pathophysiology: pancreas and beta cells
S. Migrenne (France)
Abstract

New treatments targeting pancreatic islets
R. Abi Gerges (Lebanon)
Abstract
Slide set

Functional insulin therapy: mere words or real solution
Z. Turki (Tunisia)
Abstract
Slide set

Central nervous system and metabolism
S. Migrenne (France)
Abstract

Bariatric surgery, treatment of diabetes?
Z. Turki (Tunisia)
Abstract
Slide set

Should we need to reconsider our therapeutic goals in 2011?
R. Abi Gerges (Lebanon)
Abstract
Slide set

Short Oral presentations of 7 posters (2nd series)

Rôle du polymorphisme du gène CTLA-4 dans la susceptibilité au diabète type 1 : résultats d’une étude familiale et d’une étude cas-témoins dans le sud tunisien
F. Zouidi (Tunisia)
Abstract
Slide set

Polymorphisme R620W du gène de la PTPN22 et diabète type 1 dans la population tunisienne
A. Bouaziz Abed (Tunisia)

Cognitive and psychological characteristic in diabetic foot patients
A. Marseglia (Italy)
Slide set

GDM diagnosis after the IADPSQ recommendations
J. Craus (Malta)
Abstract
Slide set

Low glycemic index & hypocaloric diet therapy vs conventional approach in GDM/OAV, after medical nutritional therapy failure
A. Napoli (Italy)
Slide set

Adiponectinemia, glucose status, insulin secretion and insulin resistance in obese women: influence of weight loss
J. Silva-Nunes (Portugal)
Abstract
Slide set

NT-proBNP and 5-years survival in a large cohort of type 2 diabetes: the Casale Monferrato study
M. Perotto (Italy)
Abstract
Slide set

SESSION F: Controversy

HbA1C vs blood glucose: what is the best option to diagnose diabetes?
Chairman: P. Cavallo Perin (Italy)
Moderator: B. Karamanos (Greece)
HbA1C: D. Carvalho (Portugal)
Abstract
Slide set
Blood glucose: R. Malek (Algeria)
Abstract

Final lecture: Foetal programming of the cardiovascular risk: effect of maternal diabetes
J.-F. Gautier (France)
Abstract